Summary

Radiopharmaceutical CRO Market Summary

The global radiopharmaceutical CRO market size was valued at USD 1.5 billion in 2025 and is projected to grow from USD 1.7 billion in 2026 to USD 3.9 billion by 2033, at a CAGR of 12.7% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 46.0% in 2025. The market growth is driven by the expanding radioligand therapy pipeline, increasing adoption of targeted radiopharmaceuticals in oncology, and rising complexity of radiopharmaceutical clinical trials.

The growing demand for specialized imaging and dosimetry services, and increasing outsourcing of discovery, preclinical, clinical, analytical, regulatory, and logistics activities to specialized CROs are expected to further fuel the growth of the radiopharmaceutical CRO industry. The short half-lives of radioisotopes, specialized site and facility requirements, radiation safety considerations, and stringent regulatory requirements further increase the need for experienced service providers. The expansion of radiopharmaceutical development across oncology, neurology, and cardiology is expected to support demand for specialized CRO capabilities over the coming years.

Global Radiopharmaceutical CRO Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global radiopharmaceutical CRO market report based on service, radiopharmaceutical type, radionuclide, development stage, application, end user, and region:

• Service Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Clinical Development & Trial Management Services
o Clinical Development & Protocol Design
o Clinical Trial Management
o Site Management
o Patient Recruitment & Investigator Management
o Data Management & Biostatistics
o Other Clinical Services
• Preclinical Research Services
o Preclinical Pharmacology & Efficacy
o ADME & PK/PD
o Toxicology & Safety Assessment
o Others
• Imaging & Dosimetry Services
o Nuclear Imaging Services
o Image Analysis & Quantification
o Biodistribution & Functional Imaging
o Radiation Dosimetry
o Other Imaging & Dosimetry Services
• Radiochemistry Services
• Analytical Laboratory Services
• Regulatory Affairs
• Clinical Supply & Logistics
• Other Services
• Radiopharmaceutical Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Diagnostic
• Therapeutic
• Theranostic
• Radionuclide Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Diagnostic Radionuclides
• Therapeutic Radionuclides
• Development Stage Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Drug Discovery
• Preclinical
• Phase 0 / First-in-Human
• Phase I
• Phase II
• Phase III
• Phase IV
• Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Oncology
• Neurology
• Cardiology
• Infectious Diseases
• Other Applications
• End User Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Pharma & Biotech Companies
• Radiopharmaceutical Companies
• Academic & Research Institutes
• Others
• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait
o Oman
o Qatar

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. Radiopharmaceutical Type
1.2.3. Radionuclide
1.2.4. Development Stage
1.2.5. Application
1.2.6. End User
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-up Approach
1.7.4. Multivariate Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Radiopharmaceutical CRO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL Analysis

Chapter 4. Radiopharmaceutical CRO Market: Service Estimates & Trend Analysis
4.1. Radiopharmaceutical CRO Market, By Service: Segment Dashboard
4.2. Radiopharmaceutical CRO Market, By Service: Movement Analysis
4.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By Service, 2021 - 2033
4.4. Clinical Development & Trial Management Services
4.4.1. Clinical Development & Trial Management Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.4.1.1. Clinical Development & Protocol Design
4.4.1.1.1. Clinical Development & Protocol Design Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.4.1.2. Clinical Trial Management
4.4.1.2.1. Clinical Trial Management Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.4.1.3. Site Management
4.4.1.3.1. Site Management Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.4.1.4. Patient Recruitment & Investigator Management
4.4.1.4.1. Patient Recruitment & Investigator Management Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.4.1.5. Data Management & Biostatistics
4.4.1.5.1. Data Management & Biostatistics Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.4.1.6. Other Clinical Services
4.4.1.6.1. Other Clinical Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.5. Preclinical Research Services
4.5.1. Preclinical Research Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.5.1.1. Preclinical Pharmacology & Efficacy
4.5.1.1.1. Preclinical Pharmacology & Efficacy Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.5.1.2. ADME & PK/PD
4.5.1.2.1. ADME & PK/PD Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.5.1.3. Toxicology & Safety Assessment
4.5.1.3.1. Toxicology & Safety Assessment Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.5.1.4. Others
4.5.1.4.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.6. Imaging & Dosimetry Services
4.6.1. Imaging & Dosimetry Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.6.1.1. Nuclear Imaging Services
4.6.1.1.1. Nuclear Imaging Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.6.1.2. Image Analysis & Quantification
4.6.1.2.1. Image Analysis & Quantification Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.6.1.3. Biodistribution & Functional Imaging
4.6.1.3.1. Biodistribution & Functional Imaging Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.6.1.4. Radiation Dosimetry
4.6.1.4.1. Radiation Dosimetry Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.6.1.5. Other Imaging & Dosimetry Services
4.6.1.5.1. Other Imaging & Dosimetry Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.7. Radiochemistry Services
4.7.1. Radiochemistry Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.8. Analytical Laboratory Services
4.8.1. Analytical Laboratory Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.9. Regulatory Affairs
4.9.1. Regulatory Affairs Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.10. Clinical Supply & Logistics
4.10.1. Clinical Supply & Logistics Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
4.11. Other Services
4.11.1. Other Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 5. Radiopharmaceutical CRO Market: Radiopharmaceutical Type Estimates & Trend Analysis
5.1. Radiopharmaceutical CRO Market, By Radiopharmaceutical Type: Segment Dashboard
5.2. Radiopharmaceutical CRO Market, By Radiopharmaceutical Type: Movement Analysis
5.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By Radiopharmaceutical Type, 2021 - 2033
5.4. Diagnostic
5.4.1. Diagnostic Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
5.5. Therapeutic
5.5.1. Therapeutic Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
5.6. Theranostic
5.6.1. Theranostic Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 6. Radiopharmaceutical CRO Market: Radionuclide Estimates & Trend Analysis
6.1. Radiopharmaceutical CRO Market, By Radionuclide: Segment Dashboard
6.2. Radiopharmaceutical CRO Market, By Radionuclide: Movement Analysis
6.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By Radionuclide, 2021 - 2033
6.4. Diagnostic Radionuclides
6.4.1. Diagnostic Radionuclides Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
6.5. Therapeutic Radionuclides
6.5.1. Therapeutic Radionuclides Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 7. Radiopharmaceutical CRO Market: Development Stage Estimates & Trend Analysis
7.1. Radiopharmaceutical CRO Market, By Development Stage: Segment Dashboard
7.2. Radiopharmaceutical CRO Market, By Development Stage: Movement Analysis
7.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By Development Stage, 2021 - 2033
7.4. Drug Discovery
7.4.1. Drug Discovery Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
7.5. Preclinical
7.5.1. Preclinical Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
7.6. Phase 0 / First-in-Human
7.6.1. Phase 0 / First-in-Human Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
7.7. Phase I
7.7.1. Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
7.8. Phase II
7.8.1. Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
7.9. Phase III
7.9.1. Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
7.10. Phase IV
7.10.1. Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 8. Radiopharmaceutical CRO Market: Application Estimates & Trend Analysis
8.1. Radiopharmaceutical CRO Market, By Application: Segment Dashboard
8.2. Radiopharmaceutical CRO Market, By Application: Movement Analysis
8.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By Application, 2021 - 2033
8.4. Oncology
8.4.1. Oncology Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
8.5. Neurology
8.5.1. Neurology Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
8.6. Cardiology
8.6.1. Cardiology Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
8.7. Infectious Diseases
8.7.1. Infectious Diseases Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
8.8. Other Applications
8.8.1. Other Applications Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 9. Radiopharmaceutical CRO Market: End User Estimates & Trend Analysis
9.1. Radiopharmaceutical CRO Market, By End User: Segment Dashboard
9.2. Radiopharmaceutical CRO Market, By End User: Movement Analysis
9.3. Radiopharmaceutical CRO Market Estimates & Forecasts, By End User, 2021 - 2033
9.4. Pharma & Biotech Companies
9.4.1. Pharma & Biotech Companies Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
9.5. Radiopharmaceutical Companies
9.5.1. Radiopharmaceutical Companies Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
9.6. Academic & Research Institutes
9.6.1. Academic & Research Institutes Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
9.7. Others
9.7.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 10. Radiopharmaceutical CRO Market: Regional Estimates & Trend Analysis
10.1. Regional Market Dashboard
10.2. Regional Market Share Analysis, 2025 & 2033
10.3. North America
10.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.3.2. U.S
10.3.2.1. Key Country Dynamics
10.3.2.2. Competitive Scenario
10.3.2.3. Regulatory Framework
10.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.3.3. Canada
10.3.3.1. Key Country Dynamics
10.3.3.2. Competitive Scenario
10.3.3.3. Regulatory Framework
10.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.3.4. Mexico
10.3.4.1. Key Country Dynamics
10.3.4.2. Competitive Scenario
10.3.4.3. Regulatory Framework
10.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.4. Europe
10.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.4.2. UK
10.4.2.1. Key Country Dynamics
10.4.2.2. Competitive Scenario
10.4.2.3. Regulatory Framework
10.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.4.3. Germany
10.4.3.1. Key Country Dynamics
10.4.3.2. Competitive Scenario
10.4.3.3. Regulatory Framework
10.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.4.4. France
10.4.4.1. Key Country Dynamics
10.4.4.2. Competitive Scenario
10.4.4.3. Regulatory Framework
10.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.4.5. Italy
10.4.5.1. Key Country Dynamics
10.4.5.2. Competitive Scenario
10.4.5.3. Regulatory Framework
10.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.4.6. Spain
10.4.6.1. Key Country Dynamics
10.4.6.2. Competitive Scenario
10.4.6.3. Regulatory Framework
10.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.4.7. Denmark
10.4.7.1. Key Country Dynamics
10.4.7.2. Competitive Scenario
10.4.7.3. Regulatory Framework
10.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.4.8. Sweden
10.4.8.1. Key Country Dynamics
10.4.8.2. Competitive Scenario
10.4.8.3. Regulatory Framework
10.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.4.9. Norway
10.4.9.1. Key Country Dynamics
10.4.9.2. Competitive Scenario
10.4.9.3. Regulatory Framework
10.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.5. Asia Pacific
10.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.5.2. Japan
10.5.2.1. Key Country Dynamics
10.5.2.2. Competitive Scenario
10.5.2.3. Regulatory Framework
10.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.5.3. China
10.5.3.1. Key Country Dynamics
10.5.3.2. Competitive Scenario
10.5.3.3. Regulatory Framework
10.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.5.4. India
10.5.4.1. Key Country Dynamics
10.5.4.2. Competitive Scenario
10.5.4.3. Regulatory Framework
10.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.5.5. Thailand
10.5.5.1. Key Country Dynamics
10.5.5.2. Competitive Scenario
10.5.5.3. Regulatory Framework
10.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.5.6. South Korea
10.5.6.1. Key Country Dynamics
10.5.6.2. Competitive Scenario
10.5.6.3. Regulatory Framework
10.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.5.7. Australia
10.5.7.1. Key Country Dynamics
10.5.7.2. Competitive Scenario
10.5.7.3. Regulatory Framework
10.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.6. Latin America
10.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.6.2. Brazil
10.6.2.1. Key Country Dynamics
10.6.2.2. Competitive Scenario
10.6.2.3. Regulatory Framework
10.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.6.3. Argentina
10.6.3.1. Key Country Dynamics
10.6.3.2. Competitive Scenario
10.6.3.3. Regulatory Framework
10.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.7. MEA
10.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.7.2. South Africa
10.7.2.1. Key Country Dynamics
10.7.2.2. Competitive Scenario
10.7.2.3. Regulatory Framework
10.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.7.3. Saudi Arabia
10.7.3.1. Key Country Dynamics
10.7.3.2. Competitive Scenario
10.7.3.3. Regulatory Framework
10.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.7.4. UAE
10.7.4.1. Key Country Dynamics
10.7.4.2. Competitive Scenario
10.7.4.3. Regulatory Framework
10.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.7.5. Kuwait
10.7.5.1. Key Country Dynamics
10.7.5.2. Competitive Scenario
10.7.5.3. Regulatory Framework
10.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.7.6. Oman
10.7.6.1. Key Country Dynamics
10.7.6.2. Competitive Scenario
10.7.6.3. Regulatory Framework
10.7.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
10.7.7. Qatar
10.7.7.1. Key Country Dynamics
10.7.7.2. Competitive Scenario
10.7.7.3. Regulatory Framework
10.7.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 11. Competitive Landscape
11.1. Key Participant Categorization
11.1.1. Market Leaders
11.1.2. Emerging Players
11.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
11.3. Company Profiles
11.3.1. IQVIA Holdings Inc.
11.3.1.1. Company Overview
11.3.1.2. Financial Performance
11.3.1.3. Service Benchmarking
11.3.1.4. Strategic Initiatives
11.3.2. ICON plc
11.3.2.1. Company Overview
11.3.2.2. Financial Performance
11.3.2.3. Service Benchmarking
11.3.2.4. Strategic Initiatives
11.3.3. Charles River Laboratories
11.3.3.1. Company Overview
11.3.3.2. Financial Performance
11.3.3.3. Service Benchmarking
11.3.3.4. Strategic Initiatives
11.3.4. Thermo Fisher Scientific (PPD)
11.3.4.1. Company Overview
11.3.4.2. Financial Performance
11.3.4.3. Service Benchmarking
11.3.4.4. Strategic Initiatives
11.3.5. Labcorp Holdings Inc.
11.3.5.1. Company Overview
11.3.5.2. Financial Performance
11.3.5.3. Service Benchmarking
11.3.5.4. Strategic Initiatives
11.3.6. WuXi AppTec
11.3.6.1. Company Overview
11.3.6.2. Financial Performance
11.3.6.3. Service Benchmarking
11.3.6.4. Strategic Initiatives
11.3.7. Medpace Holdings, Inc.
11.3.7.1. Company Overview
11.3.7.2. Financial Performance
11.3.7.3. Service Benchmarking
11.3.7.4. Strategic Initiatives
11.3.8. Perceptive
11.3.8.1. Company Overview
11.3.8.2. Financial Performance
11.3.8.3. Service Benchmarking
11.3.8.4. Strategic Initiatives
11.3.9. TRACER
11.3.9.1. Company Overview
11.3.9.2. Financial Performance
11.3.9.3. Service Benchmarking
11.3.9.4. Strategic Initiatives
11.3.10. Pharmaron
11.3.10.1. Company Overview
11.3.10.2. Financial Performance
11.3.10.3. Service Benchmarking
11.3.10.4. Strategic Initiatives
11.3.11. ABX-CRO
11.3.11.1. Company Overview
11.3.11.2. Financial Performance
11.3.11.3. Service Benchmarking
11.3.11.4. Strategic Initiatives
11.3.12. PSI
11.3.12.1. Company Overview
11.3.12.2. Financial Performance
11.3.12.3. Service Benchmarking
11.3.12.4. Strategic Initiatives
11.3.13. Minerva Imaging
11.3.13.1. Company Overview
11.3.13.2. Financial Performance
11.3.13.3. Service Benchmarking
11.3.13.4. Strategic Initiatives

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Radiopharmaceutical CRO Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million/Billion)
Table 4 Global Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 5 Global Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 6 Global Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 7 Global Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 8 Global Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 9 Global Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 10 North America Radiopharmaceutical CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
Table 11 North America Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 12 North America Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 13 North America Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 14 North America Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 15 North America Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 16 North America Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 17 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 18 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 19 U.S.Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 20 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 21 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 22 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 23 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 24 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 25 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 26 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 27 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 28 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 29 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 30 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 31 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 32 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 33 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 34 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 35 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
Table 36 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 37 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 38 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 39 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 40 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 41 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 42 UK Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 43 UK Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 44 UK Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 45 UK Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 46 UK Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 47 UK Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 48 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 49 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 50 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 51 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 52 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 53 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 54 France Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 55 France Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 56 France Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 57 France Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 58 France Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 59 France Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 60 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 61 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 62 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 63 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 64 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 65 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 66 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 67 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 68 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 69 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 70 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 71 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 72 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 73 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 74 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 75 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 76 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 77 Denmark Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 78 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 79 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 80 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 81 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 82 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 83 Sweden Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 84 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 85 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 86 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 87 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 88 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 89 Norway Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 90 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
Table 91 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 92 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 93 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 94 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 95 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 96 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 97 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 98 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 99 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 100 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 101 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 102 Japan Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 103 China Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 104 China Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 105 China Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 106 China Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 107 China Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 108 China Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 109 India Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 110 India Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 111 India Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 112 India Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 113 India Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 114 India Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 115 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 116 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 117 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 118 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 119 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 120 Australia Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 121 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 122 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 123 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 124 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 125 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 126 Thailand Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 127 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 128 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 129 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 130 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 131 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 132 South Korea Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 133 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
Table 134 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 135 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 136 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 137 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 138 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 139 Latin America Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 140 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 141 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 142 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 143 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 144 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 145 Brazil Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 146 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 147 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 148 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 149 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 150 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 151 Argentina Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 152 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
Table 153 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 154 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 155 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 156 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 157 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 158 Middle East & Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 159 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 160 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 161 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 162 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 163 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 164 South Africa Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 165 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 166 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 167 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 168 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 169 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 170 UAE Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 171 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 172 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 173 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 174 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 175 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 176 Saudi Arabia Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 177 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 178 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 179 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 180 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 181 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 182 Kuwait Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 183 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 184 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 185 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 186 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 187 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 188 Qatar Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)
Table 189 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million/Billion)
Table 190 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, By Radiopharmaceutical Type, 2021 - 2033 (USD Million/Billion)
Table 191 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, By Development Stage, 2021 - 2033 (USD Million/Billion)
Table 192 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, By Radionuclide, 2021 - 2033 (USD Million/Billion)
Table 193 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, By Application, 2021 - 2033 (USD Million/Billion)
Table 194 Oman Radiopharmaceutical CRO Market Estimates and Forecasts, By End User, 2021 - 2033 (USD Million/Billion)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Market Formulation & Validation
Fig. 6 Commodity Flow Analysis
Fig. 7 Value-Chain-Based Sizing & Forecasting
Fig. 8 QFD Model Sizing & Forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market Snapshot
Fig. 11 Segment Snapshot 1
Fig. 12 Segment Snapshot 2
Fig. 13 Competitive Landscape Snapshot
Fig. 14 Parent market outlook, 2025 (USD Billion)
Fig. 15 Ancillary market outlook, 2025 (USD Billion)
Fig. 16 Radiopharmaceutical CRO Market Dynamics
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 PESTEL Analysis
Fig. 19 Radiopharmaceutical CRO Market: Service outlook and key takeaways
Fig. 20 Radiopharmaceutical CRO Market: Service movement analysis
Fig. 21 Clinical Development & Trial Management Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 22 Clinical Development & Protocol Design Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 23 Clinical Trial Management Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 24 Site Management Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 25 Patient Recruitment & Investigator Management Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 26 Data Management & Biostatistics Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 27 Other Clinical Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 28 Preclinical Pharmacology & Efficacy Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 29 ADME & PK/PD Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 30 Toxicology & Safety Assessment Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 31 Others Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 32 Imaging & Dosimetry Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 33 Nuclear Imaging Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 34 Image Analysis & Quantification Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 35 Biodistribution & Functional Imaging Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 36 Radiation Dosimetry Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 37 Other Imaging & Dosimetry Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 38 Radiochemistry Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 39 Analytical Laboratory Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 40 Regulatory Affairs Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 41 Clinical Supply & Logistics Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 42 Other Services Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 43 Radiopharmaceutical CRO Market: Radiopharmaceutical Type outlook and key takeaways
Fig. 44 Radiopharmaceutical CRO Market: Radiopharmaceutical Type movement analysis
Fig. 45 Diagnostic Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 46 Therapeutic Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 47 Theranostic Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 48 Radiopharmaceutical CRO Market: Radionuclide outlook and key takeaways
Fig. 49 Radiopharmaceutical CRO Market: Radionuclide movement analysis
Fig. 50 Diagnostic Radionuclides Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 51 Therapeutic Radionuclides Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 52 Radiopharmaceutical CRO Market: Development Stage outlook and key takeaways
Fig. 53 Radiopharmaceutical CRO Market: Development Stage movement analysis
Fig. 54 Drug Discovery Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 55 Preclinical Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 56 Phase 0 / First-in-Human Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 57 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 58 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 59 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 60 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 61 Radiopharmaceutical CRO Market: Application outlook and key takeaways
Fig. 62 Radiopharmaceutical CRO Market: Application movement analysis
Fig. 63 Oncology Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 64 Neurology Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 65 Cardiology Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 66 Infectious Diseases Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 67 Other Applications Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 68 Radiopharmaceutical CRO Market: End User outlook and key takeaways
Fig. 69 Radiopharmaceutical CRO Market: End User movement analysis
Fig. 70 Pharma & Biotech Companies Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 71 Radiopharmaceutical Companies Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 72 Academic & Research Institutes Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 73 Others Market Estimates and Forecast, 2021 - 2033 (USD Million/Billion)
Fig. 74 Regional Marketplace: Key Takeaways
Fig. 75 North America Radiopharmaceutical CRO Market estimates and forecasts, 202 - 2033 (USD Million/Billion)
Fig. 76 Key country dynamics
Fig. 77 U.S. Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 78 Key country dynamics
Fig. 79 Canada Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 80 Key country dynamics
Fig. 81 Mexico Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 82 Europe Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 83 Key country dynamics
Fig. 84 UK Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 85 Key country dynamics
Fig. 86 Germany Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 87 Key country dynamics
Fig. 88 France Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 89 Key country dynamics
Fig. 90 Italy Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 91 Key country dynamics
Fig. 92 Spain Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 93 Key country dynamics
Fig. 94 Denmark Radiopharmaceutical CRO Market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 95 Key country dynamics
Fig. 96 Sweden Radiopharmaceutical CRO Market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 97 Key country dynamics
Fig. 98 Norway Radiopharmaceutical CRO Market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 99 Asia Pacific Radiopharmaceutical CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 100 Key country dynamics